CINQAERO® is indicated as add-on therapy in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus another medicinal product for maintenance treatment.1
*Data from two randomised, double-blind, placebo-controlled clinical trials (n=953) in a targeted patient population with inadequately controlled asthma and elevated blood eosinophils (≥400 cells/μL). Patients received either placebo (n=476) or CINQAERO® (n=477). Both treatments were added to standard of care.1,2
[Pooled analysis of two studies where patients with blood eosinophils ≥400 cells/µL and one or more exacerbations in the previous year were randomised to reslizumab 3mg/kg by i.v. infusion (n=477) or placebo (n=476) every four weeks.]
CINQAERO® is provided as a concentrate for solution for infusion, in a single-use vial.1
Reslizumab is a humanised monoclonal antibody that binds specifically to interleukin-5, a major cytokine responsible for the differentiation, maturation, recruitment and activation of eosinophils - which have a role in inadequately controlled asthma.1,2
CINQAERO® targets IL-5 to reduce eosinophilic airway inflammation and reduce blood eosinophils.1,2
Teva Pharma B.V.
Marketing Authorisation number(s)
Let's Talk Respiratory is our educational programme of supportive materials, resources and some of the latest news in respiratory for both you and your patients. Our aim is to support you and encourage you, help empower patients and to make a real difference to the lives of those living with asthma and COPD.
1. CINQAERO® Summary of Product Characteristics. Teva Pharmaceuticals Europe B.V.
2. Castro M, Zangrilli J, Wechsler ME et al. Lancet Respir Med, 2015; 3: 355-66.
To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.